1. Home
  2. AVTX vs KOPN Comparison

AVTX vs KOPN Comparison

Compare AVTX & KOPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVTX
    SELLHOLDBUYas of in 22 minutes
  • KOPN
    SELLHOLDBUYas of a day ago
  • Stock Information
  • Founded
  • AVTX 2011
  • KOPN 1984
  • Country
  • AVTX United States
  • KOPN United States
  • Employees
  • AVTX N/A
  • KOPN N/A
  • Industry
  • AVTX Biotechnology: Pharmaceutical Preparations
  • KOPN Semiconductors
  • Sector
  • AVTX Health Care
  • KOPN Technology
  • Exchange
  • AVTX Nasdaq
  • KOPN Nasdaq
  • Market Cap
  • AVTX 88.4M
  • KOPN 282.1M
  • IPO Year
  • AVTX 2015
  • KOPN 1992
  • Fundamental
  • Price
  • AVTX $7.45
  • KOPN $1.42
  • Analyst Decision
  • AVTX Strong Buy
  • KOPN Strong Buy
  • Analyst Count
  • AVTX 5
  • KOPN 4
  • Target Price
  • AVTX $36.75
  • KOPN $2.63
  • AVG Volume (30 Days)
  • AVTX 102.5K
  • KOPN 2.4M
  • Earning Date
  • AVTX 05-12-2025
  • KOPN 05-13-2025
  • Dividend Yield
  • AVTX N/A
  • KOPN N/A
  • EPS Growth
  • AVTX N/A
  • KOPN N/A
  • EPS
  • AVTX N/A
  • KOPN N/A
  • Revenue
  • AVTX $820,000.00
  • KOPN $44,266,305.00
  • Revenue This Year
  • AVTX N/A
  • KOPN $21.20
  • Revenue Next Year
  • AVTX N/A
  • KOPN $13.55
  • P/E Ratio
  • AVTX N/A
  • KOPN N/A
  • Revenue Growth
  • AVTX N/A
  • KOPN 0.60
  • 52 Week Low
  • AVTX $4.35
  • KOPN $0.56
  • 52 Week High
  • AVTX $34.46
  • KOPN $2.33
  • Technical
  • Relative Strength Index (RSI)
  • AVTX 49.65
  • KOPN 43.13
  • Support Level
  • AVTX $7.21
  • KOPN $1.16
  • Resistance Level
  • AVTX $8.40
  • KOPN $1.40
  • Average True Range (ATR)
  • AVTX 0.88
  • KOPN 0.15
  • MACD
  • AVTX 0.07
  • KOPN -0.01
  • Stochastic Oscillator
  • AVTX 43.13
  • KOPN 42.86

Stock Price Comparison Chart: AVTX vs KOPN

AVTX
KOPN
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober202501,0002,0003,0004,0005,0006,0007,0008,0009,00010,00011,000AVTX VS KOPN

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical stage biotechnology company focused on the treatment of immune dysregulation. The company's lead asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

About KOPN Kopin Corporation

Kopin Corp is a provider of high-performance application-specific optical solutions consisting of high-resolution microdisplays and optics, subassemblies, and headsets. It serves soldiers, avionics, armored vehicles training and simulation military applications, and others. Its product portfolio includes Microdisplays, Spatial Light Modulators, Optical Modules, Medical, Training, and Simulation. Geographically, it derives a majority of its revenue from the Americas and also has a presence in Asia-Pacific; Europe, and Other Countries.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use